This site uses cookies to store information on your computer. Learn more x

DSM – proposed appointment to the Managing Board of Directors

Heerlen, NL, 25 Feb 2011 08:35 CET

The Supervisory Board of Royal DSM is pleased to announce that it will propose to the Annual General Meeting of Shareholders on 28 April 2011 to appoint Mr. Stefan Doboczky to the Managing Board of DSM with responsibility for DSM’s Pharma cluster as well as the regional responsibility of DSM’s activities in Asia, with effect from 1 May 2011.

Mr. Doboczky will operate from two office locations, in the Netherlands and in Asia in line with the further internationalization of DSM, as set out in the latest DSM strategy announced in September 2010.

Stefan Doboczky (1967), an Austrian national is at present President of the Business Group DSM Anti-Infectives. He has built a strong track record within the DSM Pharma cluster and has particular experience with business development in high growth economies, including Asia. Before joining DSM in 1998, Mr. Doboczky worked at ARCO Chemicals in Austria and the UK.

In DSM Mr. Doboczky held several senior positions in DSM Pharmaceutical Products, before he became Vice President and Business Unit Director China for DSM Anti-Infectives based in Beijing in 2006. In 2009 he became the President of DSM Anti-Infectives.

Mr. Doboczky studied at the Technical University of Vienna, Austria and he holds a Master in Chemistry and a PhD in Natural and Technical Sciences as well as an MBA from IMD in Lausanne.

In view of the ongoing formation of the joint venture between DSM Anti-Infectives and Sinochem, Mr. Doboczky will for the time being also continue in his position as President DSM Anti-Infectives.